Understanding Heart Failure With Preserved Ejection Fraction in a Diabetic Way
- PMID: 33688851
- PMCID: PMC7907634
- DOI: 10.1016/j.jacbts.2020.12.017
Understanding Heart Failure With Preserved Ejection Fraction in a Diabetic Way
Keywords: apolipoprotein; diabetes; heart failure; mediation analysis; proteomics.
Conflict of interest statement
This work was supported by the National Institutes of Health (AG061034, HL155318) and the American Heart Association (20CDA35310184). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction.JACC Basic Transl Sci. 2021 Feb 10;6(2):89-99. doi: 10.1016/j.jacbts.2020.11.011. eCollection 2021 Feb. JACC Basic Transl Sci. 2021. PMID: 33665511 Free PMC article.
References
-
- Kurano M., Tsukamoto K., Shimizu T. Protection against insulin resistance by apolipoprotein M/sphingosine-1-phosphate. Diabetes. 2020;69:867–881. - PubMed
-
- Kurano M., Tsuneyama K., Morimoto Y. Apolipoprotein M protects lipopolysaccharide-treated mice from death and organ injury. Thromb Haemost. 2018;118:1021–1035. - PubMed
-
- Pofi R., Giannetta E., Galea N. Diabetic cardiomyopathy progression is triggered by miR122-5p and involves extracellular matrix: a 5-year prospective study. J Am Coll Cardiol Img. 2020 Nov 18 [E-pub ahead of print] - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
